Alerts will be sent to your verified email
Verify Email
KERALAYUR
|
Kerala Ayurveda
|
Zenotech Laboratorie
|
Bafna Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-54.59 % | 9.5 % | -52.11 % |
|
5yr average Equity Multiplier
|
17.91 | 1.13 | 3.77 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 0.36 | 0.42 |
|
5yr Avg Net Profit Margin
|
-3.82 % | -13.89 % | -36.55 % |
|
Price to Book
|
50.2 | 2.94 | 3.23 |
|
P/E
|
0.0 | 85.58 | 28.39 |
|
5yr Avg Cash Conversion Cycle
|
-36.58 Days | -1217.81 Days | 0.18 Days |
|
Inventory Days
|
51.76 Days | 145.01 Days | 87.65 Days |
|
Days Receivable
|
51.0 Days | 61.38 Days | 132.64 Days |
|
Days Payable
|
164.59 Days | 477.06 Days | 210.48 Days |
|
5yr Average Interest Coverage Ratio
|
0.36 | -4.03 | -5.68 |
|
5yr Avg ROCE
|
0.83 % | 9.71 % | -11.61 % |
|
5yr Avg Operating Profit Margin
|
3.63 % | 5.56 % | -21.98 % |
|
5 yr average Debt to Equity
|
11.28 | 0.04 | 1.41 |
|
5yr CAGR Net Profit
|
24.88 % | n/a | 12.0 % |
|
5yr Average Return on Assets
|
-3.11 % | 8.4 % | -16.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
33.14 % | 68.84 % | 75.0 % |
|
Share Pledged by Promoters
|
23.56 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-28.38 % | 0.0 | -15.02 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.01 % | 0.0 | 0.0 |
|
Kerala Ayurveda
|
Zenotech Laboratorie
|
Bafna Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|